Sotera Health Co at Barclays Global Healthcare Conference Transcript
Good morning, everybody. My name is Luke Sergott. I cover life sciences tools and diagnostics at Barclays. If you're not in Miami, you don't lose a voice, how are you going to prove you were there.
So with me, I have Michael Petras, CEO of Sotera Health. Thanks again, for making it down. Packed house on a Thursday, we're wrapping up the conference, and you guys are bringing it home for us. So, I guess we could start if you want to give a couple high-level thoughts or something prepared there, and then we could dig in some questions, if you like.
Yes. Great. Thanks, Luke, for having us, and appreciate your support and Barclays Group overall. Happy to be here.
Before we begin, some of the statements I'm going to make are made considered forward-looking statements. Please refer to our SEC filings for a description of the risks and uncertainties that could cause our actual results to differ materially from
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |